Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Frequency of Hepatitis B Virus Resistance Mutations in Women Using Tenofovir Gel as Pre-Exposure Prophylaxis.

Viruses - 19 Jun 2019

Baxter Cheryl, Ngcapu Sinaye, Blackard Jason T, Powell Eleanor A, Penton Patricia K, Abdool Karim Salim S

Abstract excerpt

Intermittent use of a single antiretroviral agent in the presence of a replicating virus could potentially increase the development of antiviral resistance. The pericoital, before-and-after sex, dosing regimen used in the Centre for the AIDS Programme of Research in South Africa (CAPRISA) 004 tenofovir gel trial meant that women who were infected with hepatitis B virus (HBV) were exposed intermittently to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to DNA, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to Hepatitis B

Share to Hepatitis B virus

Share to HIV Infections

Share to South Africa

Share to Tenofovir

Source

Open in PubMed Open full text

Identifiers

PMID: 31248149
DOI: 10.3390/v11060569
PMCID: PMC6630952

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Frequency of Hepatitis B Virus Resistance Mutations in Women Using Tenofovir Gel as Pre-Exposure Prophylaxis.PMID 31248149Read ↗

Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women.Semantic proximity Read ↗

Acceptability of tenofovir gel as a vaginal microbicide among women in a phase I trial a mixed-methods study,Semantic proximity Read ↗

A Phase 1 Randomized, Open Label, Rectal Safety, Acceptability, Pharmacokinetic, and Pharmacodynamic Study of Three Formulations of Tenofovir 1% Gel (the CHARM-01 Study).Semantic proximity Read ↗

Evidence of Tenofovir Resistance in Chronic Hepatitis B Virus (HBV) Infection: An Observational Case Series of South African AdultsSemantic proximity Read ↗

Tenofovir diphosphate in dried blood spots and HIV-1 resistance in South AfricaSemantic proximity Read ↗

Evidence of tenofovir resistance in chronic hepatitis B virus (HBV) infection: An observational case series of South African adultsSemantic proximity Read ↗

Low prevalence of transmitted K65R and other tenofovir resistance mutations across different HIV-1 subtypes: implications for pre-exposure prophylaxis.Semantic proximity Read ↗

Prevalence of HIV-1 drug resistance among women screening for HIV prevention trials in KwaZulu-Natal, South Africa (MTN-009).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.